TABLE 3: Histopathological results.
| Histopathological findings | Group 1 | Group 2 | Group 3 | Group 4 |
|---|---|---|---|---|
| Control | Sepsis | Sepsis + cefazolin | Sepsis + cefazolin + etanercept | |
| (n = 7) | (n = 7) | (n = 7) | (n = 7) | |
| Tubular necrosis | 0 | 2.71 ± 0.48a | 2.14 ± 0.37a,b | 1 ± 0a,b,c |
| Tubular atrophy | 0 | 2.85 ± 0.37a | 2 ± 0a,b | 1 ± 0a,b,c |
| Regenerative atypia | 0 | 0 | 0 | 0 |
| Hydropic degeneration | 0 | 3 ± 0 | 2 ± 0 | 1 ± 0 |
| Interstitial fibrosis | 0 | 0 | 0 | 0 |
| Loss of brush border | 0 | 2.85 ± 0.37a | 2.14 ± 0.37a,b | 0.14 ± 0.37b,c |
ap < 0.05 in comparison with control group. bp < 0.05 in comparison with sepsis group. cp < 0.05 in comparison with sepsis + cefazolin group.